Home / Science / Pig Organs for Humans: Transplant Solution Arrives
Pig Organs for Humans: Transplant Solution Arrives
2 Mar
Summary
- US firm aims to farm pigs for human transplant organs by 2028.
- Genetically modified pig organs will reduce rejection risk.
- Global donor shortages drive innovation in xenotransplantation.

Within two years, pigs are anticipated to be farmed for human transplant organs, addressing worldwide donor shortages. A prominent American company intends to establish a large medical facility to raise sufficient pigs for an estimated 6,000 hearts, kidneys, and other organs annually by 2028. These animals undergo DNA editing to minimize patient rejection risks, with organ growth controlled to match human size.
The demand for organs, particularly kidneys affected by conditions such as diabetes, heart disease, and high blood pressure, is immense. The UK's NHS faces a record 8,200 patients on its transplant waiting list, while donations are declining. Similar shortages are a global concern, affecting countries like the USA and China.
Recent advancements in xenotransplantation have seen surgeons successfully transplant lab-grown pig organs into terminally ill patients. While these procedures currently serve as a bridge to human donors, scientists are working to refine them so pig organs can last for many years. United Therapeutics' chief scientific officer, Dr. David Ayares, views xenotransplantation as a crucial solution to the ongoing organ scarcity and plans to trial pig heart transplants for critically ill patients this year.




